Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Der p 1 substrates on airway epithelial and endothelial cell surfaces are a group of proteins targeted by the cysteine protease allergen Der p 1 from the house dust mite Dermatophagoides pteronyssinus. These substrates include critical junctional proteins such as Occludin, Claudin-1, Zonula occludens-1 (ZO-1), and E-cadherin, which are essential for maintaining the physical integrity of the airway barrier [Wan et al., 1999; Gough et al., 2001]. Proteolytic cleavage of these proteins by Der p 1 increases epithelial permeability, facilitating the entry of allergens and pathogens into the subepithelial space. Additionally, Der p 1 cleaves cell surface receptors like CD23 (low-affinity IgE receptor) and CD25 (IL-2 receptor alpha chain), which modulates immune signaling and promotes a Th2-biased allergic response [Schulz et al., 1998]. The allergen also activates Protease-activated receptor 2 (PAR-2), inducing the secretion of pro-inflammatory cytokines such as IL-6 and IL-8 [Asokananthan et al., 2002]. Therapeutic interventions aim to inhibit the enzymatic activity of Der p 1 using small molecule cysteine protease inhibitors, thereby protecting these substrates from degradation and preventing the initiation of allergic inflammation and asthma exacerbations.
Inhibition of the Der p 1 cysteine protease prevents the proteolytic cleavage and degradation of these substrates, thereby preserving airway barrier integrity and preventing pro-inflammatory signaling cascades.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dermatophagoides pteronyssinus allergen 1 substrates (Der p 1 substrates).